A former portfolio manager for CR Intrinsic Investors, a division of Stamford-based SAC Capital, was sentenced Monday to nine years in federal prison for his role in a $275 million insider trading scheme involving pharmaceutical firms and drugs to treat Alzheimer's disease. Mathew Martoma took part in a scheme that U.S. District Judge Paul G. Gardephe called "deeply corrosive to our financial markets" -- the most lucrative insider trading scheme ever, involving $275 million in illegal profits and avoided losses.
http://ift.tt/1onvkm1
http://ift.tt/1onvkm1
No comments:
Post a Comment